Nadaaniyan: Ibrahim Ali Khan, Khushi Kapoor recreate Kuch Kuch Hota Hai with Archana Puran Singh to announce release date, film will be out on...
Move on from "Pyaar dosti hai" as the Gen-Z believes "Pyaar arrangement hai," and that's what Ibrahim Ali Khan and Khushi ...
Ibrahim Ali Khan And Khushi Kapoor Starrer ‘Nadaaniyan’ Release Date Out - DEETS
'Nadaaniyan' is Ibrahim Ali Khan’s debut film which also stars Khushi Kapoor in pivotal roles. Mumbai: Ibrahim Ali Khan’s ...
Mid Day1d
Ibrahim and Khushi recreate Kuch Kuch Hota Hai scene
Ibrahim Ali Khan is all set to make his debut with the Netflix romantic drama ’Nadaaniyan’ alongside Khushi Kapoor. Archana ...
Actor Vidyut Jammwal on visiting Maha Kumbh, Prayagraj: Maa’s happiness is above all awards, it's a very special feeling
Vidyut Jammwal calls his recent visit to the Maha Kumbh Mela in Prayagraj one of his biggest achievements. Especially so, because he fulfilled his mother’s wish ...
Polar Preet on why she's challenging herself to travel solo to the North Pole
Preet Chandi MBE, better known as Polar Preet, has broken several world records, including in 2023 when she made the longest ...
Wall Street Journal21d
Rani Therapeutics Holdings Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
FierceBiotech24d
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
Reuters25d
Drug developer Maze Therapeutics eyes up to $728 million valuation in US IPO
Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...